Butylphthalide Injection
- Categories:Qijian News
- Author:QIjian
- Origin:QIjian
- Time of issue:2021-07-30
- Views:0
(Summary description)We applied for registration of product Butylphthalide Injection and on July 15,2021 received the notification from CFDA(Acceptance number: CXHL2101298国), "Butylphthalide Injection" Class II New Drugs enters the Clinical Phase.
Butylphthalide Injection
(Summary description)We applied for registration of product Butylphthalide Injection and on July 15,2021 received the notification from CFDA(Acceptance number: CXHL2101298国), "Butylphthalide Injection" Class II New Drugs enters the Clinical Phase.
- Categories:Qijian News
- Author:QIjian
- Origin:QIjian
- Time of issue:2021-07-30
- Views:0
We applied for registration of product Butylphthalide Injection and on July 15,2021 received the notification from CFDA(Acceptance number: CXHL2101298国), "Butylphthalide Injection" Class II New Drugs enters the Clinical Phase.
Scan the QR code to read on your phone
Related News
Contact Us
Contact us
Contact Us
ADD: No.707 Chaofan street, High-Tech Industrial Development Zone, Changchun City, Jilin province, China
Service Hotline:0086-431-86561075
Fax:0086-431-88794098
Email:export@qijianbio.com
Copyright:Jilin Qijian Bio-pharmaceutical Co., Ltd. by:300.cn 吉ICP备20003293号 SEO